Bio-Rad Laboratories (BIO) earnings per share (EPS)

Earnings per share · fiscal 2025
$27.85

Bio-Rad Laboratories (BIO) reported diluted earnings per share of $27.85 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$65.36. Figures as of 17 Nov 2026, 23:34 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings per share, fiscal 2025
$27.85
Growth, 5 years
−26.1% a year
Growth, 10 years
+22.3% a year
Highest on record
$140.83fiscal 2021
Lowest on record
-$121.79fiscal 2022
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Bio-Rad Laboratories earnings per share (EPS), in more detail

Over the five fiscal years to 2025 diluted earnings per share shrank at a compound 26.1% a year; over ten years the rate was 22.3% a year. Across the 18 fiscal years on record (2008–2025), the highest was $140.83 in fiscal 2021 and the lowest -$121.79 in fiscal 2022.

History · 18 fiscal years

Earnings per share by fiscal year

Bio-Rad Laboratories earnings per share (EPS), year by year

Bio-Rad Laboratories (BIO) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2025$27.85—
2024-$65.36—
2023-$21.82—
2022-$121.79 186.5% down
2021$140.83 11.4% up
2020$126.47 117.0% up
2019$58.27 381.6% up
2018$12.10 197.3% up
2017$4.07 362.5% up
2016$0.88 76.3% down
2015$3.71 21.6% up
2014$3.05 13.4% up
2013$2.69 53.5% down
2012$5.78 8.1% down
2011$6.29 4.6% down
2010$6.59 26.7% up
2009$5.20 60.5% up
2008$3.24—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

Earnings per share at health care companies of similar size

Earnings per share of Bio-Rad Laboratories and comparable companies
CompanyEarnings per shareFiscal year
Ensign Group ENSG$5.842025
Vaxcyte PCVX-$5.632025
Bio-Rad Laboratories BIO$27.852025
Molina Healthcare MOH$8.922025
Qiagen QGEN$2.042025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BIO

Bio-Rad Laboratories, figure by figure

Bio-Rad Laboratories (BIO) overview: price, valuation and scorecardAll health care companies by market value

Bio-Rad Laboratories earnings per share (EPS): questions and answers

What is Bio-Rad Laboratories's diluted earnings per share?

Bio-Rad Laboratories (BIO) reported diluted earnings per share of $27.85 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$65.36.

What is the growth rate of Bio-Rad Laboratories's diluted earnings per share?

Over the five fiscal years to 2025 diluted earnings per share shrank at a compound 26.1% a year; over ten years the rate was 22.3% a year.

What are the highest and lowest diluted earnings per share figures on record for Bio-Rad Laboratories?

Across the 18 fiscal years on record (2008–2025), the highest was $140.83 in fiscal 2021 and the lowest -$121.79 in fiscal 2022.

How is Bio-Rad Laboratories's diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Bio-Rad Laboratories (BIO) earnings per share (EPS)”, data as of 17 November 2026. https://funkfolio.com/stock/BIO/eps

Underlying data: the company's filings with the SEC and Yahoo Finance.